MoMs Hips a Grinding Dilemma for Hospitals, Doctors, FDA
During the two days, panel members heard a mind-boggling array of words and phrases to describe the damage to bone, tissue, and blood resulting from MoM devices:
Tribocorrosion, trunnions, fracture of resurfacing systems, edge wear, microseparation, pseudotumors and asceptic lymphocytic vasculiis-associated lesions, voltage effects, infections, post-operative nerve palsy, prosthesis loosening, implant breakage or fracture, femoral neck fractures and heterotopic ossification, loss of mobility and pain, and mechanically assisted corrosion, to name just a few.
Starting a decade ago, newer MoM devices were seen as a safer alternative to prostheses made of polyethylene or ceramic, which wore out faster, and which released particles that could accumulate in local tissue and erode the bone.
Metal devices, which would last longer, held a promise to solve that problem, because they were seen as more appropriate for younger people who wanted to remain active in their 60s and 70s and beyond without having to undergo a revision surgery.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- Large Employers Trimming Healthcare Spending
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital